Tag: ai drug discovery
Posted in General
Deep Genomics adds life sciences veteran as CEO to support its evolution into biopharma firm
Brian O’Callaghan to lead Toronto firm as founder transitions to chief innovation officer. Toronto-based artificial intelligence (AI) drug development startup Deep Genomics has hired…
Posted in General
After buying Cyclica and Valence, Recursion secures $50 million USD from Nvidia for drug discovery
Recursion, a US-based biotech firm, opened a new Canadian headquarters in Toronto last month. Computing giant Nvidia has invested $50 million USD in Recursion…